Suit Alleging Pharma Firm's Board Downplayed Risk of Liver Drug Is Sent to Delaware

Delaware Law Weekly

Feb 2, 2021

The case was moved from New York under a clause in Intercept's bylaws specifying derivative actions against the company are to be addressed in a state or federal court in Delaware,…